REGENEREX PHARMA, INC. Proceeds from Common Stock Issued
REGENEREX PHARMA, INC. reported Proceeds from Common Stock Issued of $711.40 thousand for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-31
- REGENEREX PHARMA, INC. proceeds from issuance of common stock for the quarter ending 2014-11-30 was $0.00.
- REGENEREX PHARMA, INC. proceeds from issuance of common stock for the quarter ending 2014-08-31 was $4.66K, a 81.36% decline year-over-year.
- REGENEREX PHARMA, INC. proceeds from issuance of common stock for the quarter ending 2014-05-31 was $25.00K, a 25.00% increase year-over-year.
- REGENEREX PHARMA, INC. proceeds from issuance of common stock for the quarter ending 2014-02-28 was $10.00K.
- REGENEREX PHARMA, INC. proceeds from issuance of common stock for fiscal 2025 was $2.55M.
- REGENEREX PHARMA, INC. proceeds from issuance of common stock for fiscal 2014 was $39.66K, a 7.77% decline from fiscal 2013.
- REGENEREX PHARMA, INC. proceeds from issuance of common stock for fiscal 2013 was $43.00K.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 47 month | Proceeds from Issuance of Common Stock 50 month | Proceeds from Issuance of Common Stock 53 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $711.40K 10-KT · filed 2026-08-31 | ||||||
| 2025-03-31 | $2.55M 10-KT · filed 2026-08-31 | ||||||
| 2014-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $4.66K derived: sum of 2 quarters · filed 2015-03-03 | $29.66K derived: sum of 3 quarters · filed 2015-03-03 | $39.66K 10-K · filed 2015-03-03 | $160.77K 10-K · filed 2015-03-03 | ||
| 2014-08-31 | $4.66K 10-Q · filed 2014-10-20 | $29.66K derived: sum of 2 quarters · filed 2014-10-20 | $39.66K 10-Q · filed 2014-10-20 | $37.66K derived: sum of 4 quarters · filed 2015-03-03 | $160.77K 10-Q · filed 2014-10-20 | ||
| 2014-05-31 | $25.00K 10-Q · filed 2014-07-23 | $35.00K 10-Q · filed 2014-07-23 | $33.00K derived: sum of 3 quarters · filed 2015-03-03 | $58.00K derived: sum of 4 quarters · filed 2015-03-03 | $156.11K 10-Q · filed 2014-07-23 | ||
| 2014-02-28 | $10.00K derived: 10-K 12 month − 3 quarters · filed 2015-03-03 | $8.00K derived: sum of 2 quarters · filed 2015-03-03 | $33.00K derived: sum of 3 quarters · filed 2015-03-03 | $53.00K derived: sum of 4 quarters · filed 2015-03-03 | |||
| 2013-11-30 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $23.00K derived: sum of 2 quarters · filed 2015-03-03 | $43.00K derived: sum of 3 quarters · filed 2015-03-03 | $43.00K 10-K · filed 2015-03-03 | |||
| 2013-08-31 | $25.00K 10-Q · filed 2014-10-20 | $45.00K derived: sum of 2 quarters · filed 2014-10-20 | $45.00K 10-Q · filed 2014-10-20 | ||||
| 2013-05-31 | $20.00K 10-Q · filed 2014-07-23 | $20.00K 10-Q · filed 2014-07-23 |